When it comes to policing pharma, the FTC says it’s on ‘an incredible winning streak’; FDA OKs — but doesn’t require — a non-cancer-causing chemical for sterilizing devices

Taking stock of the drug industry, from the lab to the medicine chest

January 24, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Graeme Jennings/Washington Examiner via AP STAT+ | When it comes to policing pharma, the FTC says it's on 'an incredible winning streak' The Biden administration deployed the FTC to review patents and mergers, among other things, as a way to address high prescription drug costs. By Ed Silverman STAT+ | FDA OKs — but doesn't require — a non-cancer-causing chemical for sterilizing devices Medical device manufacturers can now more easily use a chemical that doesn't cause cancer to sterilize their devices, after the FDA's decision. By Lizzy Lawrence As NIH grant runs out, Dog Aging Project founders look to raise up to $50 million The project — a beacon of hope for human longevity research — has been studying the biology of aging in nearly 50,000 companion dogs. By Deborah Balthazar

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser